1. Home
  2. TNGX vs ASG Comparison

TNGX vs ASG Comparison

Compare TNGX & ASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • ASG
  • Stock Information
  • Founded
  • TNGX 2014
  • ASG 1986
  • Country
  • TNGX United States
  • ASG United States
  • Employees
  • TNGX N/A
  • ASG N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • ASG Investment Managers
  • Sector
  • TNGX Health Care
  • ASG Finance
  • Exchange
  • TNGX Nasdaq
  • ASG Nasdaq
  • Market Cap
  • TNGX 317.4M
  • ASG 315.2M
  • IPO Year
  • TNGX N/A
  • ASG N/A
  • Fundamental
  • Price
  • TNGX $1.95
  • ASG $4.92
  • Analyst Decision
  • TNGX Strong Buy
  • ASG
  • Analyst Count
  • TNGX 7
  • ASG 0
  • Target Price
  • TNGX $12.33
  • ASG N/A
  • AVG Volume (30 Days)
  • TNGX 817.7K
  • ASG 324.3K
  • Earning Date
  • TNGX 05-07-2025
  • ASG 01-01-0001
  • Dividend Yield
  • TNGX N/A
  • ASG 8.09%
  • EPS Growth
  • TNGX N/A
  • ASG N/A
  • EPS
  • TNGX N/A
  • ASG N/A
  • Revenue
  • TNGX $42,069,000.00
  • ASG N/A
  • Revenue This Year
  • TNGX N/A
  • ASG N/A
  • Revenue Next Year
  • TNGX N/A
  • ASG N/A
  • P/E Ratio
  • TNGX N/A
  • ASG N/A
  • Revenue Growth
  • TNGX 15.17
  • ASG N/A
  • 52 Week Low
  • TNGX $1.72
  • ASG $4.47
  • 52 Week High
  • TNGX $12.02
  • ASG $5.71
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 37.66
  • ASG 34.44
  • Support Level
  • TNGX $1.80
  • ASG $4.78
  • Resistance Level
  • TNGX $2.01
  • ASG $4.94
  • Average True Range (ATR)
  • TNGX 0.21
  • ASG 0.14
  • MACD
  • TNGX 0.01
  • ASG -0.02
  • Stochastic Oscillator
  • TNGX 31.94
  • ASG 26.27

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About ASG Liberty All-Star Growth Fund Inc.

Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.

Share on Social Networks: